Real-world outcomes of the TECNIS Eyhance IOL

evidence from a high-volume retrospective Argentinian study

Authors

  • Tomás Martín Castro Centro de Ojos Quilmes. Buenos Aires, Argentina
  • Luciano Perrone Centro de Ojos Quilmes. Buenos Aires, Argentina
  • Nazarena Nasif Centro de Ojos Quilmes. Buenos Aires, Argentina
  • Franco Perrone Centro de Ojos Quilmes. Buenos Aires, Argentina
  • Manuela Masseroni Centro de Ojos Quilmes. Buenos Aires, Argentina
  • José Russian Centro de Ojos Quilmes. Buenos Aires, Argentina
  • Diana Calero-Vera Centro de Ojos Quilmes. Buenos Aires, Argentina
  • Lucas Aguirre Centro de Ojos Quilmes. Buenos Aires, Argentina
  • Gerardo Valvecchia Centro de Ojos Quilmes. Buenos Aires, Argentina

DOI:

https://doi.org/10.70313/2718.7446.v18.n4.466

Keywords:

intraocular lenses, cataract surgery, Eyhance, functional vision

Abstract

Purpose: To evaluate visual and refractive outcomes obtained with an intraocular lens (IOL) in a large, unselected cohort at an Argentine cataract surgery center.

Methods: This retrospective consecutive-case study included patients implanted with the TECNIS Eyhance IOL (ICB00) between November 2020 and November 2024. Postoperative evaluation was performed at one month. Recorded variables included preoperative corrected distance visual acuity (CDVA) and postoperative uncorrected distance visual acuity (UDVA) in logarithmic scale, uncorrected near visual acuity (UNVA) at 32 cm, manifest spherical equivalent (SE), implanted IOL power, and the presence of complications. Near visual acuity was measured with a Jaeger chart until March 2023 and subsequently with a standardized logarithmic chart (Byromat); Jaeger values were converted to logMAR for analysis.

Results: A total of 899 eyes from 518 patients were included. The mean implanted IOL power was 22.1 ±2.5 D. Preoperative SE averaged 1.23 ±2.3 D, decreasing to -0.42 ±0.50 D postoperatively. Preoperative CDVA was 0.16 logMAR, improving to a postoperative UDVA of 0.04 logMAR. No eye lost lines of vision. UNVA demonstrated functional performance, with most measurements between J1 and J3 during the initial phase. Using the logarithmic chart, mean UNVA at 32 cm was 0.26 ±0.11 logMAR, with most eyes between 0.2–0.3 logMAR.

Conclusion: The Eyhance IOL provided reliable uncorrected distance and functional near visual outcomes, with a favorable safety profile throughout the four-year study period.

Downloads

Download data is not yet available.

References

1. Fernández J, Rocha-de-Lossada C, Zamorano-Martín F, Rodríguez-Calvo-de-Mora M, Rodríguez-Vallejo M. Positioning of enhanced monofocal intraocular lenses between conventional monofocal and extended depth of focus lenses: a scoping review. BMC Ophthalmol 2023; 23(1): 101. doi:10.1186/s12886-023-02844-1.

2. Li J, Sun B, Zhang Y et al. Comparative efficacy and safety of all kinds of intraocular lenses in presbyopia-correcting cataract surgery: a systematic review and meta-analysis. BMC Ophthalmol 2024; 24(1): 172. doi:10.1186/s12886-024-03446-1.

3. Nagyova D, Tappeiner C, Blaha A, Goldblum D, Kyroudis D. Visual outcomes and patient satisfaction with extended monovision-an innovative strategy to achieve spectacle independence in refractive lens exchange. J Clin Med 2025; 14(16): 5684. doi: 10.3390/jcm14165684.

4. Srinivasan S, Nyankerh C, Hull J, Suryakumar R. Meta-analysis of defocus curves of monofocal, enhanced monofocal and extended depth of focus IOLs. BMJ Open Ophthalmol 2025; 10(1): e002025. doi:10.1136/bmjophth-2024-002025.

5. Bianchi GR. Lentes intraoculares de profundidad de foco extendida (EDOF): revisión narrativa. Oftalmol Clin Exp 2025; 18(3): e277-e286. doi: https://doi.org/10.70313/2718.7446.v18.n3.447.

6. Jeon YJ, Yoon Y, Kim TI, Koh K. Comparison between an intraocular lens with extended depth of focus (Tecnis Symfony ZXR00) and a new monofocal intraocular lens with enhanced intermediate vision (Tecnis Eyhance ICB00). Asia Pac J Ophthalmol (Phila) 2021; 10(6): 542-547. doi:10.1097/APO.0000000000000439.

7. Gigon E, Bouthour W, Panos GD, Pajic B, Massa H. Real world outcomes of the new Tecnis Eyhance IOL. Eur J Ophthalmol 2023; 33(3): 1390-1397. doi:10.1177/11206721221146675.

8. Singh G, Sidhharthan KS, Reddy JK, Sundaram V, Thulasidas M. Comparison of visual outcomes in patients implanted with Tecnis Eyhance ICB00 and 1-Piece ZCB00 monofocal intraocular lenses. Indian J Ophthalmol 2024; 72(2): 181-184. doi:10.4103/IJO.IJO_681_23.

9. Negishi K, Masui S, Ayaki M, Torii H, Yotsukura E, Nishi Y. Clinical results and factors affecting visual function in eyes implanted with an enhanced monofocal intraocular lens. Clin Ophthalmol 2023; 17: 3965-3973. doi:10.2147/OPTH.S438599.

10. Janekova A, Polachova M, Piñero DP, Studeny P. Comparison of visual acuity and optical quality between higher-order aspheric monofocal and standard introcular lenses. Int J Ophthalmol 2025; 18(4): 598-605. doi:10.18240/ijo.2025.04.05.

11. Corbett D, Black D, Roberts TV et al. Quality of vision clinical outcomes for a new fully-refractive extended depth of focus Intraocular Lens. Eye (Lond) 2024; 38(Suppl 1): 9-14. doi:10.1038/s41433-024-03039-8.

12. Alfonso-Bartolozzi B, Martínez-Alberquilla I, Fernández-Vega-Cueto L et al. Optical and visual outcomes of a new refractive extended depth of focus intraocular lens. J Refract Surg 2025; 41(4): e333-e341. doi:10.3928/1081597X-20250221-02.

13. Niknahad A, Wu Z, Son HS, Auffarth GU, Khoramnia R, Łabuz G. Evaluation of Clareon Vivity and PureSee intraocular lenses: optical quality, depth of focus and misalignment effects. Sci Rep 2025; 15(1): 26943. doi:10.1038/s41598-025-07970-y.

14. Son HS, Łabuz G, Wu Z et al. Optical differentiation of presbyopia-correcting intraocular lenses with improved intermediate vision from a single manufacturer. J Refract Surg 2025; 41(10): e1098-e1105. doi:10.3928/1081597X-20250805-05.

Published

2025-12-22

Issue

Section

Original Articles

How to Cite

1.
Castro TM, Perrone L, Nasif N, et al. Real-world outcomes of the TECNIS Eyhance IOL: evidence from a high-volume retrospective Argentinian study. Oftalmol. Clín. Exp. 2025;18(4):e467-e480. doi:10.70313/2718.7446.v18.n4.466

Similar Articles

11-20 of 359

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)